BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23523611)

  • 1. Nanotheraputics.
    Ravi Kumar MN; Blanco-Prieto MJ; Waterhouse DN
    Cancer Lett; 2013 Jul; 334(2):155-6. PubMed ID: 23523611
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticancer drug delivery with nanoparticles.
    Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U
    In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theranostic nanomedicine for cancer.
    Sumer B; Gao J
    Nanomedicine (Lond); 2008 Apr; 3(2):137-40. PubMed ID: 18373419
    [No Abstract]   [Full Text] [Related]  

  • 4. Nanomedicine in cancer treatment.
    Yih TC; Wei C
    Nanomedicine; 2005 Jun; 1(2):191-2. PubMed ID: 17292078
    [No Abstract]   [Full Text] [Related]  

  • 5. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.
    Pridgen EM; Langer R; Farokhzad OC
    Nanomedicine (Lond); 2007 Oct; 2(5):669-80. PubMed ID: 17976029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
    Bharali DJ; Mousa SA
    Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine: the promise and challenges in cancer chemotherapy.
    Naguib YW; Cui Z
    Adv Exp Med Biol; 2014; 811():207-33. PubMed ID: 24683034
    [No Abstract]   [Full Text] [Related]  

  • 8. Nanomedicine and drug delivery.
    Wei C; Wei W; Morris M; Kondo E; Gorbounov M; Tomalia DA
    Med Clin North Am; 2007 Sep; 91(5):863-70. PubMed ID: 17826106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine for multimodality treatment of cancer.
    Mi Y; Guo Y; Feng SS
    Nanomedicine (Lond); 2012 Dec; 7(12):1791-4. PubMed ID: 23249329
    [No Abstract]   [Full Text] [Related]  

  • 10. Engineering the nanoparticle-protein interface for cancer therapeutics.
    Saie AA; Ray M; Mahmoudi M; Rotello VM
    Cancer Treat Res; 2015; 166():245-73. PubMed ID: 25895872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards the use of nanoparticles in cancer therapy and imaging.
    Pauwels EK; Erba P
    Drug News Perspect; 2007 May; 20(4):213-20. PubMed ID: 17637933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface-active liposomes for targeted cancer therapy.
    Sofou S
    Nanomedicine (Lond); 2007 Oct; 2(5):711-24. PubMed ID: 17976032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in combination therapies based on nanoparticles for efficacious cancer treatment: an analytical report.
    Mignani S; Bryszewska M; Klajnert-Maculewicz B; Zablocka M; Majoral JP
    Biomacromolecules; 2015 Jan; 16(1):1-27. PubMed ID: 25426779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biofunctionalized, phosphonate-grafted, ultrasmall iron oxide nanoparticles for combined targeted cancer therapy and multimodal imaging.
    Das M; Mishra D; Dhak P; Gupta S; Maiti TK; Basak A; Pramanik P
    Small; 2009 Dec; 5(24):2883-93. PubMed ID: 19856326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Influencing the Delivery Efficiency of Cancer Nanomedicines.
    Ullah R; Wazir J; Khan FU; Diallo MT; Ihsan AU; Mikrani R; Aquib M; Zhou X
    AAPS PharmSciTech; 2020 May; 21(4):132. PubMed ID: 32409932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer chemoprevention by polyphenols and their potential application as nanomedicine.
    Tabrez S; Priyadarshini M; Urooj M; Shakil S; Ashraf GM; Khan MS; Kamal MA; Alam Q; Jabir NR; Abuzenadah AM; Chaudhary AG; Damanhouri GA
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2013; 31(1):67-98. PubMed ID: 23534395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Strategies in Cancer Nanomedicine.
    Tong R; Kohane DS
    Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine: magnetic nanoparticles hit the target.
    Amirfazli A
    Nat Nanotechnol; 2007 Aug; 2(8):467-8. PubMed ID: 18654342
    [No Abstract]   [Full Text] [Related]  

  • 19. Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
    Ruttala HB; Ramasamy T; Madeshwaran T; Hiep TT; Kandasamy U; Oh KT; Choi HG; Yong CS; Kim JO
    Arch Pharm Res; 2018 Feb; 41(2):111-129. PubMed ID: 29214601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promising approaches in using magnetic nanoparticles in oncology.
    Mikhaylov G; Vasiljeva O
    Biol Chem; 2011 Nov; 392(11):955-60. PubMed ID: 21848508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.